Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Ambu A/S stock

AMBU B.CO
DK0060946788
A2JAHY

Price

118.90 DKK
Today +/-
-0.46 DKK
Today %
-2.82 %
P

Ambu A/S stock price

DKK
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Ambu A/S stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Ambu A/S stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Ambu A/S stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Ambu A/S's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Ambu A/S Stock Price History

DateAmbu A/S Price
11/15/2024118.90 DKK
11/14/2024122.30 DKK
11/13/2024118.60 DKK
11/12/2024120.75 DKK
11/11/2024125.85 DKK
11/8/2024123.85 DKK
11/7/2024117.35 DKK
11/6/2024119.65 DKK
11/5/2024117.20 DKK
11/4/2024128.40 DKK
11/1/2024129.70 DKK
10/31/2024126.90 DKK
10/30/2024128.45 DKK
10/29/2024133.25 DKK
10/28/2024130.35 DKK
10/25/2024128.25 DKK
10/24/2024127.75 DKK
10/23/2024128.15 DKK
10/22/2024127.00 DKK
10/21/2024129.00 DKK
10/18/2024129.35 DKK

Ambu A/S Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Ambu A/S, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Ambu A/S from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Ambu A/S’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Ambu A/S. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Ambu A/S’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Ambu A/S’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Ambu A/S’s growth potential.

Ambu A/S Revenue, EBIT and net profit per share

DateAmbu A/S RevenueAmbu A/S EBITAmbu A/S Net Income
2029e10.52 B DKK2.08 B DKK1.42 B DKK
2028e8.92 B DKK1.7 B DKK1.17 B DKK
2027e7.91 B DKK1.39 B DKK940.63 M DKK
2026e6.98 B DKK1.08 B DKK747.43 M DKK
2025e6.16 B DKK869.93 M DKK583.98 M DKK
20245.39 B DKK645 M DKK235 M DKK
20234.78 B DKK302 M DKK168 M DKK
20224.44 B DKK150 M DKK93 M DKK
20214.01 B DKK340 M DKK247 M DKK
20203.57 B DKK428 M DKK241 M DKK
20192.82 B DKK480 M DKK317 M DKK
20182.61 B DKK563 M DKK337 M DKK
20172.36 B DKK450 M DKK301 M DKK
20162.08 B DKK356 M DKK250 M DKK
20151.89 B DKK241 M DKK152 M DKK

Ambu A/S Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B DKK)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B DKK)NET INCOME (B DKK)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20152016201720182019202020212022202320242025e2026e2027e2028e2029e
1.892.082.362.612.823.574.014.444.785.396.166.987.918.9210.52
-10.3213.0010.668.2126.4912.5010.747.4512.9014.3013.2313.3312.8017.96
50.8753.9356.5259.3658.0562.0162.3758.1056.8259.3851.9545.8840.4835.8930.42
0.961.121.331.551.642.212.52.582.713.200000
0.150.250.30.340.320.240.250.090.170.240.580.750.941.171.42
-64.4720.4011.96-5.93-23.972.49-62.3580.6539.88148.0928.1325.8424.6820.90
247.36243.92242.97247.7247.46246.56251.77253.99260.48266.3300000
---------------
Details

Keystats

ⓘ

Revenue and Growth

The Ambu A/S Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Ambu A/S is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M DKK)RECEIVABLES (M DKK)OTHER REC. (M DKK)INVENTORIES (B DKK)OTHER CURRENT LIAB. (M DKK)CURRENT ASSETS (B DKK)TANGIBLE ASSETS (B DKK)LONG-T. INVEST. (M DKK)LONG-T. REC. (M DKK)INTANGIBLE ASSETS (B DKK)GOODWILL (B DKK)OTHER NON-CURRENT ASSETS (M DKK)NON-CURRENT ASSETS (B DKK)TOTAL ASSETS (B DKK)LIABILITIESCOMMON STOCK (M DKK)ADDITIONAL PAID-IN CAPITAL (M DKK)RETAINED EARNINGS (B DKK)OTHER EQUITY (M DKK)UNREAL. GAINS/LOSSES (M DKK)EQUITY (B DKK)LIABILITIES (M DKK)PROVISIONS (M DKK)OTHER SHORT-TERM LIAB. (M DKK)SHORT-TERM DEBTS (M DKK)LONG-TERM DEBT PORTION (M DKK)SHORT-TERM REC. (B DKK)LONG-T. LIAB. (B DKK)DEFERRED TAXES (M DKK)OTHER LIAB. (M DKK)LONG-T. LIABILITIES (B DKK)DEBT (B DKK)TOTAL CAPITAL (B DKK)
2015201620172018201920202021202220232024
                   
483519631209864187157615
473418437478474521699747766745
19221626214333599484
0.280.290.310.380.510.520.751.220.911.08
352831364060648984115
0.850.790.820.991.161.241.612.32.012.64
0.280.270.370.460.520.660.851.281.161.13
0000000000
5640000000
0.280.420.431.141.241.441.741.942.051.7
0.810.820.781.511.551.51.51.621.571.53
3061981548790427085160
1.41.581.683.253.43.694.134.914.854.52
2.252.372.54.234.564.935.747.226.867.15
                   
121121122126126126129129135135
3237570000000
0.760.711.041.671.92.173.723.755.055.31
125126658915473106379211145
0000000000
1.040.991.281.882.182.373.954.265.395.59
115104160194266259364600359490
0000000000
259238237276737738553482511494
771400000000
251703444363797275
0.450.411.10.471.011.040.981.160.941.06
0.70.930.081.31.151.40.761.770.510.48
175240668118834
483736534152323019914
0.770.970.121.881.371.510.811.790.520.5
1.221.371.222.352.382.551.792.951.471.56
2.252.372.54.234.564.935.747.226.867.15
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Ambu A/S provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Ambu A/S's financial health and stability.

Assets

Ambu A/S's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Ambu A/S must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Ambu A/S after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Ambu A/S's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M DKK)DEPRECIATION (M DKK)DEFERRED TAXES (M DKK)CHANGES IN WORKING CAPITAL (M DKK)NON-CASH ITEM (M DKK)PAID INTEREST (M DKK)PAID TAXES (M DKK)NET CASH FLOW FROM OPERATING ACTIVITIES (M DKK)CAPITAL EXPENDITURES (M DKK)CASH FLOW FROM INVESTING ACTIVITIES (M DKK)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M DKK)INTEREST INCOME AND EXPENSES (M DKK)NET DEBT CHANGE (M DKK)NET CHANGE IN EQUITY (B DKK)CASH FLOW FROM FINANCING ACTIVITIES (M DKK)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M DKK)TOTAL DIVIDENDS PAID (M DKK)NET CHANGE IN CASH FLOW (M DKK)FREE CASH FLOW (M DKK)SHARE-BASED COMPENSATION (M DKK)
201520162017201820192020202120222023
152250450563306428340-26168
96102105115109181216351348
000000000
-107-67-72-106126-305-221-213-99
6784-21-18-8-9-7-17101
0000000063
3775914044102277915
20836946255453329532895518
-104-143-159-236-261-430-584-558-326
-118-239-141-1,161-261-430-874-558-326
-14-9618-92500-29000
000000000
-3273-279496-158143-743648-1,313
-0.04-0.310.030.230.040.071.330.011.09
-92-80-323651-216114512586-222
0-101300110
-45-46-75-92-101-96-73-750
450-24457-22-34123-30
104226303318272-135-256-463192
000000000

Ambu A/S stock margins

The Ambu A/S margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ambu A/S. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ambu A/S.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Ambu A/S's sales revenue. A higher gross margin percentage indicates that the Ambu A/S retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Ambu A/S's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Ambu A/S's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Ambu A/S's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Ambu A/S. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Ambu A/S's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Ambu A/S Margin History

Ambu A/S Gross marginAmbu A/S Profit marginAmbu A/S EBIT marginAmbu A/S Profit margin
2029e59.38 %19.76 %13.47 %
2028e59.38 %19.08 %13.14 %
2027e59.38 %17.62 %11.89 %
2026e59.38 %15.52 %10.71 %
2025e59.38 %14.12 %9.48 %
202459.38 %11.96 %4.36 %
202356.82 %6.32 %3.52 %
202258.1 %3.38 %2.09 %
202162.37 %8.47 %6.15 %
202062.01 %12 %6.76 %
201958.05 %17.02 %11.24 %
201859.36 %21.6 %12.93 %
201756.52 %19.11 %12.78 %
201653.93 %17.08 %12 %
201550.87 %12.76 %8.05 %

Ambu A/S Stock Sales Revenue, EBIT, Earnings per Share

The Ambu A/S earnings per share therefore indicates how much revenue Ambu A/S has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Ambu A/S earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Ambu A/S's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Ambu A/S’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Ambu A/S's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Ambu A/S Revenue, EBIT and net profit per share

DateAmbu A/S Sales per ShareAmbu A/S EBIT per shareAmbu A/S Earnings per Share
2029e45.34 DKK0 DKK6.11 DKK
2028e38.43 DKK0 DKK5.05 DKK
2027e34.08 DKK0 DKK4.05 DKK
2026e30.06 DKK0 DKK3.22 DKK
2025e26.55 DKK0 DKK2.52 DKK
202420.24 DKK2.42 DKK0.88 DKK
202318.33 DKK1.16 DKK0.64 DKK
202217.5 DKK0.59 DKK0.37 DKK
202115.94 DKK1.35 DKK0.98 DKK
202014.47 DKK1.74 DKK0.98 DKK
201911.4 DKK1.94 DKK1.28 DKK
201810.52 DKK2.27 DKK1.36 DKK
20179.69 DKK1.85 DKK1.24 DKK
20168.54 DKK1.46 DKK1.02 DKK
20157.64 DKK0.97 DKK0.61 DKK

Ambu A/S business model

Ambu A/S is a Danish company that manufactures and distributes medical products. The company was founded in 1937 and initially specialized in the production of electrodes for medical devices. Over time, Ambu has expanded its business to various medical products. Ambu's business model is based on the development and marketing of innovative medical products. The company places great value on research and development, investing a significant portion of its revenue into this area each year. Ambu operates seven research and development facilities worldwide and employs over 700 staff in this area. Ambu operates globally in three divisions: Anaesthesia, Patient Monitoring & Diagnostics, and Emergency Care. In the Anaesthesia division, the company offers products such as anaesthesia masks, ventilation bags, and disposable laryngoscopes. These products are used by anaesthesiologists and intensive care nurses to intubate and ventilate patients. In the Patient Monitoring & Diagnostics division, the company offers products such as electrodes, probes, and other accessories for monitoring vital parameters. Ambu's patient monitoring systems enable the monitoring of patients in hospitals, clinics, and other medical facilities. In the Emergency Care division, Ambu offers products such as defibrillators, ventilation devices, and portable ventilation bags that are used by emergency services, paramedics, and other emergency medical services. Ambu's products are designed to provide life-saving assistance in emergency situations. Ambu is a leading provider of disposable products in the medical industry. The company believes that disposable products are the best choice for patient safety and hygiene. Disposable products minimize the risk of infection and contamination while improving hygiene in medical facilities. Ambu is committed to minimizing the environmental impact of its products. The company uses environmentally friendly materials in the manufacture of its products and ensures that its products can be safely disposed of after use. Ambu strives to promote sustainability in all aspects of its business. In summary, Ambu A/S is a leading provider of medical products that focuses on the development and marketing of innovative medical products. The company operates in three divisions and offers a wide range of products tailored to the needs of patients and medical professionals. Ambu is also committed to minimizing the environmental impact of its products and promoting sustainability. Ambu A/S is one of the most popular companies on Eulerpool.com.

Ambu A/S SWOT Analysis

Strengths

Ambu A/S has several strengths that contribute to its competitive advantage:

  • Strong brand reputation and recognition in the medical device industry.
  • Innovative and technologically advanced products that meet customer needs.
  • Wide range of product offerings catering to different medical specialties.
  • Global distribution network providing access to diverse markets.
  • Good financial performance and steady revenue growth.

Despite its strengths, Ambu A/S also faces certain weaknesses that need consideration:

  • Relatively high product prices compared to competitors.
  • Dependency on key suppliers for critical components.
  • Limited presence in emerging markets.
  • Regulatory and compliance challenges in different regions.

Ambu A/S can leverage the following opportunities to drive growth:

  • Increasing demand for minimally invasive medical devices.
  • Expanding into emerging markets with growing healthcare infrastructure.
  • Partnerships and collaborations with healthcare institutions and professionals.
  • Advancements in technology and digital healthcare solutions.
  • Acquisition or licensing of complementary products or technologies.

Ambu A/S should be aware of the following threats that could impact its business:

  • Intense competition from both established and emerging players.
  • Rapidly changing regulatory landscape affecting product approvals.
  • Challenges related to intellectual property protection.
  • Geopolitical and economic uncertainties impacting global business operations.
  • Potential disruptions in the supply chain due to unforeseen events.

Weaknesses

Despite its strengths, Ambu A/S also faces certain weaknesses that need consideration:

  • Relatively high product prices compared to competitors.
  • Dependency on key suppliers for critical components.
  • Limited presence in emerging markets.
  • Regulatory and compliance challenges in different regions.

Ambu A/S can leverage the following opportunities to drive growth:

  • Increasing demand for minimally invasive medical devices.
  • Expanding into emerging markets with growing healthcare infrastructure.
  • Partnerships and collaborations with healthcare institutions and professionals.
  • Advancements in technology and digital healthcare solutions.
  • Acquisition or licensing of complementary products or technologies.

Ambu A/S should be aware of the following threats that could impact its business:

  • Intense competition from both established and emerging players.
  • Rapidly changing regulatory landscape affecting product approvals.
  • Challenges related to intellectual property protection.
  • Geopolitical and economic uncertainties impacting global business operations.
  • Potential disruptions in the supply chain due to unforeseen events.

Opportunities

Ambu A/S can leverage the following opportunities to drive growth:

  • Increasing demand for minimally invasive medical devices.
  • Expanding into emerging markets with growing healthcare infrastructure.
  • Partnerships and collaborations with healthcare institutions and professionals.
  • Advancements in technology and digital healthcare solutions.
  • Acquisition or licensing of complementary products or technologies.

Ambu A/S should be aware of the following threats that could impact its business:

  • Intense competition from both established and emerging players.
  • Rapidly changing regulatory landscape affecting product approvals.
  • Challenges related to intellectual property protection.
  • Geopolitical and economic uncertainties impacting global business operations.
  • Potential disruptions in the supply chain due to unforeseen events.

Threats

Ambu A/S should be aware of the following threats that could impact its business:

  • Intense competition from both established and emerging players.
  • Rapidly changing regulatory landscape affecting product approvals.
  • Challenges related to intellectual property protection.
  • Geopolitical and economic uncertainties impacting global business operations.
  • Potential disruptions in the supply chain due to unforeseen events.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Ambu A/S Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Ambu A/S historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Ambu A/S shares outstanding

The number of shares was Ambu A/S in 2023 — This indicates how many shares 260.48 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Ambu A/S earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Ambu A/S's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Ambu A/S’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Ambu A/S's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Ambu A/S stock splits

In Ambu A/S's history, there have been no stock splits.

Ambu A/S dividend history and estimates

In 2023, Ambu A/S paid a dividend amounting to 0 DKK. Dividend means that Ambu A/S distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Ambu A/S provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Ambu A/S’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Ambu A/S's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Ambu A/S Dividend History

DateAmbu A/S Dividend
2029e1.81 DKK
2028e1.49 DKK
2027e1.2 DKK
2026e0.95 DKK
2025e0.74 DKK
20210.29 DKK
20200.29 DKK
20190.38 DKK
20180.4 DKK
20170.37 DKK
20160.31 DKK
20150.19 DKK

Ambu A/S dividend payout ratio

In 2023, Ambu A/S had a payout ratio of 29.59%. The payout ratio indicates the percentage of the company's profits that Ambu A/S distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Ambu A/S represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Ambu A/S could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Ambu A/S's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Ambu A/S Payout Ratio History

DateAmbu A/S Payout ratio
2029e29.59 %
2028e29.59 %
2027e29.59 %
2026e29.59 %
2025e29.59 %
202429.58 %
202329.59 %
202229.61 %
202129.56 %
202029.59 %
201929.66 %
201829.4 %
201729.87 %
201630.25 %
201530.92 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Ambu A/S.

Ambu A/S latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.52 DKK-0.55 DKK (-205.05 %)2024 Q4
6/30/20240.45 DKK0.5 DKK (11.23 %)2024 Q3
3/31/20240.61 DKK0.54 DKK (-10.89 %)2024 Q2
12/31/20230.26 DKK0.35 DKK (35.87 %)2024 Q1
9/30/20230.29 DKK0.33 DKK (15.3 %)2023 Q4
6/30/20230.2 DKK0.19 DKK (-4.33 %)2023 Q3
3/31/20230.17 DKK0.06 DKK (-64.35 %)2023 Q2
12/31/20220.06 DKK0.09 DKK (48.51 %)2023 Q1
9/30/2022-0.38 DKK-0.51 DKK (-32.88 %)2022 Q4
6/30/20220.09 DKK0.06 DKK (-30.15 %)2022 Q3
1
2
3
4
5
...
7

Eulerpool ESG Scorecard© for the Ambu A/S stock

Eulerpool World ESG Rating (EESG©)

94/ 100

🌱 Environment

95

👫 Social

96

🏛️ Governance

92

Environment

Scope 1 - Direct Emissions
3,687
Scope 2 - Indirect emissions from purchased energy
20,316
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
24,003
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees59
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Ambu A/S shareholders

%
Name
Stocks
Change
Date
14.17525 % NP Louis-Hansen ApS32,896,414952,5129/30/2023
7.52503 % Schroder Investment Management North America Inc.17,463,29406/30/2024
5.38926 % Capital Research Global Investors12,506,831-187,1549/30/2024
5.26509 % Kovstrup (Inga)12,218,668155,2619/30/2023
3.42507 % Allianz Global Investors GmbH7,948,544-14,0099/30/2024
2.93630 % Hesse (Hannah)6,814,257112,7399/30/2023
2.35004 % The Vanguard Group, Inc.5,453,72435,3199/30/2024
2.27956 % Brown Capital Management, LLC5,290,160-198,3616/30/2024
2.22707 % Artisan Partners Limited Partnership5,168,354-179,5206/30/2024
1.93308 % Norges Bank Investment Management (NBIM)4,486,083-150,1466/30/2024
1
2
3
4
5
...
10

Ambu A/S Executives and Management Board

Ms. Britt Meelby Jensen(47)
Ambu A/S Chief Executive Officer, Member of the Executive Board (since 2019)
Compensation 18.5 M DKK
Mr. Joergen Jensen(54)
Ambu A/S Independent Chairman of the Board
Compensation 1.52 M DKK
Mr. Christian Sagild(63)
Ambu A/S Independent Vice Chairman of the Board
Compensation 934,000 DKK
Ms. Susanne Larsson(55)
Ambu A/S Independent Director
Compensation 844,000 DKK
Mr. Michael Del Prado(60)
Ambu A/S Independent Director
Compensation 842,000 DKK
1
2
3
4

Most common questions regarding Ambu A/S

What values and corporate philosophy does Ambu A/S represent?

Ambu A/S represents a corporate philosophy based on certain key values. These values include innovation, quality, and a focus on improving patient outcomes. Ambu aims to provide innovative medical solutions that enhance the efficiency and safety of medical procedures. The company strives to maintain a high standard of quality in its product offerings, ensuring reliability and accuracy for healthcare professionals. Ambu's mission is to enable medical professionals to make better decisions and improve patient care. With a commitment to these values, Ambu A/S aims to be a trusted leader in the medical device industry.

In which countries and regions is Ambu A/S primarily present?

Ambu A/S is primarily present in various countries and regions worldwide. With its global presence, Ambu A/S operates in several key markets, including Europe, North America, and Asia-Pacific. The company's products and services cater to customers across numerous geographies, facilitating access to innovative medical solutions. Ambu A/S leverages its extensive international network to deliver high-quality healthcare devices and support healthcare professionals in improving patient outcomes. With a strong presence in multiple countries and regions, Ambu A/S demonstrates its commitment to serving customers and driving advancements in medical technology on a global scale.

What significant milestones has the company Ambu A/S achieved?

Some significant milestones achieved by Ambu A/S include continuous innovation in the field of single-use endoscopy, leading to the development of Ambu® aScope™, an innovative solution for visualizing the airways. The company has also achieved global recognition for their breakthrough product, Ambu® BlueSensor™ electrodes, which are used in monitoring patient vital signs during surgery. Ambu A/S has expanded its presence across multiple countries, establishing a strong global footprint. Moreover, the company has received several prestigious awards, including the Red Dot Design Award and the Medical Design Excellence Award, affirming their commitment to providing high-quality medical devices.

What is the history and background of the company Ambu A/S?

Ambu A/S is a Danish company specializing in medical devices and equipment. Established in 1937, Ambu has a rich history and a strong background in the healthcare industry. The company's focus lies in developing innovative solutions for diagnostics and patient monitoring, including products such as endoscopes and anesthesia masks. Ambu has a global presence, with operations in more than 120 countries and partnerships with various healthcare providers. Over the years, Ambu has earned a reputation for its high-quality products and commitment to improving patient care. With its extensive experience and expertise, Ambu A/S continues to be a leading player in the medical technology sector.

Who are the main competitors of Ambu A/S in the market?

The main competitors of Ambu A/S in the market include Medtronic, Philips Healthcare, and Smiths Medical.

In which industries is Ambu A/S primarily active?

Ambu A/S is primarily active in the medical device industry.

What is the business model of Ambu A/S?

Ambu A/S is a Danish company specializing in the development, manufacturing, and marketing of medical devices. Its business model revolves around providing innovative solutions for healthcare professionals, with a focus on respiratory care and patient monitoring. Ambu offers a wide range of high-quality products, such as flexible endoscopes, anesthesia devices, and single-use consumables. By combining expertise in engineering, medical science, and digital technology, Ambu aims to improve patient care, enhance clinical efficiency, and reduce healthcare costs. With a commitment to continuous research and development, Ambu strives to provide medical professionals with state-of-the-art solutions that prioritize patient safety and comfort.

What is the P/E ratio of Ambu A/S 2024?

The Ambu A/S P/E ratio is 134.75.

What is the P/S ratio of Ambu A/S 2024?

The Ambu A/S P/S ratio is 5.87.

What is the Quality Investing of Ambu A/S?

The Quality Investing for Ambu A/S is 4/10.

What is the revenue of Ambu A/S 2024?

The Ambu A/S revenue is 5.39 B DKK.

How high is the profit of Ambu A/S 2024?

The Ambu A/S profit is 235 M DKK.

What is the business model of Ambu A/S

Ambu A/S is a Danish company specializing in the development, production, and marketing of medical products. It was founded in 1937 and is headquartered in Copenhagen. The company has branches in various parts of the world. Ambu is focused on three main business areas: anesthesia, patient monitoring, and diagnostics. In the anesthesia field, Ambu offers devices and instruments used in anesthesia procedures, including laryngeal tubes, masks, and ventilator bags. In patient monitoring, Ambu provides a range of products, including electrodes for measuring brain activity, accessories for EKG and pulse oximetry, and non-invasive blood pressure monitors. In the diagnostics field, Ambu offers endoscopes used in the examination of body cavities and internal organs. The company follows a business model focused on innovation and technological advancement. It invests a significant portion of its revenue in research and development to bring new and improved products to the market that meet customer requirements and contribute to improving medical care. Ambu also emphasizes high product quality and safety throughout the value chain, from development and production to marketing and customer support. In addition to product sales, Ambu provides comprehensive support and training opportunities to its customers, building strong long-term relationships. Overall, Ambu is a leading company in the field of medical technology, dedicated to improving medical care through innovative and effective products.

What is the Ambu A/S dividend?

Ambu A/S pays a dividend of 0 DKK distributed over 1 payouts per year.

How often does Ambu A/S pay dividends?

Ambu A/S pays out a dividend 1 times a year.

What is the Ambu A/S ISIN?

The ISIN of Ambu A/S is DK0060946788.

What is the Ambu A/S WKN?

The WKN of Ambu A/S is A2JAHY.

What is the Ambu A/S ticker?

The ticker of Ambu A/S is AMBU B.CO.

How much dividend does Ambu A/S pay?

Over the past 12 months, Ambu A/S paid a dividend of 0.29 DKK . This corresponds to a dividend yield of about 0.24 %. For the coming 12 months, Ambu A/S is expected to pay a dividend of 0.74 DKK.

What is the dividend yield of Ambu A/S?

The current dividend yield of Ambu A/S is 0.24 %.

When does Ambu A/S pay dividends?

Ambu A/S pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Ambu A/S?

Ambu A/S paid dividends every year for the past 5 years.

What is the dividend of Ambu A/S?

For the upcoming 12 months, dividends amounting to 0.74 DKK are expected. This corresponds to a dividend yield of 0.63 %.

In which sector is Ambu A/S located?

Ambu A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ambu A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ambu A/S from 12/17/2021 amounting to 0.29 DKK, you needed to have the stock in your portfolio before the ex-date on 12/15/2021.

When did Ambu A/S pay the last dividend?

The last dividend was paid out on 12/17/2021.

What was the dividend of Ambu A/S in the year 2023?

In the year 2023, Ambu A/S distributed 0 DKK as dividends.

In which currency does Ambu A/S pay out the dividend?

The dividends of Ambu A/S are distributed in DKK.

All fundamentals about Ambu A/S

Our stock analysis for Ambu A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ambu A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.